"The Fed said they were 'honored' to host President Trump, so the temperature has clearly been turned down. We'll see what ...

Alphabet is growing fast in core and cloud segments, though rising AI capex is pressuring free cash flow and returns. Learn ...

Sarepta Therapeutics (SRPT) in focus as the biotech says the death of a patient who had received its gene therapy Elevidys ...

Lithium Argentina sees strong Q1 2025 margins, scalable growth to 200K+ tons with DLE tech, and untapped upside from ...

Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

Dow faces significant headwinds, tariffs, and weak global demand. Is it a good time to buy the dip after the dividend cut and ...

NerdWallet’s shift toward vertical integration is boosting profitability, with shares trading cheaply relative to growth. See ...

Workday is a compelling Buy opportunity with strong margins, AI potential, and 20-30% upside despite growth concerns. Read ...

Bloom Energy surged on AI hype and an Oracle deal, but valuation looks stretched and risks are rising ahead of earnings. Read ...

CVB Financial faces muted loan growth and stable margins, but steady earnings and solid yield support modest upside. Learn ...

Special Opportunities Fund offers 8.5% yield with exposure to CEFs, SPACs, and equities, but carries long-term ...